ST Pharm Co.,Ltd.
KOE: 237690.KQ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- KOSDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Geun-Jo Im
- Employees
- 566
- Headquarters
- Seoul, South Korea
- IPO year
- 2016
- Market cap
- ₩3.2T
- Website
- http://www.stpharm.co.kr
Loading 237690…
Loading profile data…Frequently asked questions about 237690
What does ST Pharm Co.,Ltd. (237690.KQ) do?
ST Pharm Co. Ltd., a contract development manufacturing organization, provides products for pharmaceutical and non-pharmaceutical area in South Korea. The company offers chemistry manufacturing control (CMC) services, which includes analytical method development; in-house reference standard testing; analytical method qualification/validation; an...
Where does 237690.KQ trade?
ST Pharm Co.,Ltd. (237690.KQ) trades on the KOSDAQ.
What sector is 237690.KQ in?
ST Pharm Co.,Ltd. (237690.KQ) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of ST Pharm Co.,Ltd.?
Geun-Jo Im is the chief executive officer of ST Pharm Co.,Ltd. (237690.KQ).
Where is ST Pharm Co.,Ltd. headquartered?
ST Pharm Co.,Ltd. is headquartered in South Korea.
Does 237690.KQ pay a dividend?
Yes — ST Pharm Co.,Ltd. (237690.KQ) paid a trailing twelve-month dividend of KRW 500.00 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 237690.KQ go public?
ST Pharm Co.,Ltd. (237690.KQ) completed its initial public offering in 2016.